MedTrace Logo

Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris

NCT03003247 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 364

Last updated 2017-12-18

No results posted yet for this study

Summary

Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris

Conditions

  • Acne Vulgaris

Interventions

DRUG

IDP-120 Gel

IDP-120 Gel is a combination product

DRUG

IDP 120 Component A Gel

Monad of Component A

DRUG

IDP 120 Component B Gel

Monad of Component B

DRUG

IDP 120 Vehicle Gel

Vehicle

Sponsors & Collaborators

  • Bausch Health Americas, Inc.

    lead INDUSTRY

Principal Investigators

  • Anya Loncaric · Valeant Pharmaceuticals

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
9 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-08-31
Completion
2016-09-30

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03003247 on ClinicalTrials.gov